Efficacy of metformin on postprandial plasma triglyceride concentration by administration timing in patients with type 2 diabetes mellitus: a randomized crossover pilot study
ConclusionsPreprandial metformin administration significantly reduced plasma triglyceride level during meal testing without marked exacerbation of gastrointestinal adverse effects. Our results suggest that a simple change in the timing of metformin administration represents a novel approach for enhancing triglyceride ‐lowering strategies in patients with type 2 diabetes mellitus and postprandial hypertriglyceridemia.This article is protected by copyright. All rights reserved.
Source: Journal of Diabetes Investigation - Category: Endocrinology Authors: Daisuke Sato,
Katsutaro Morino,
Seiichiro Ogaku,
Akiko Tsuji,
Kimihiro Nishimura,
Osamu Sekine,
Satoshi Ugi,
Hiroshi Maegawa Tags: Original Article Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Gastroenterology | Heartburn | Metformin | Study